PFIZER INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections
Phase 3
Completed
- Conditions
- Acute Otitis Media
- Interventions
- Drug: amoxicillin/clavulanate postassium (Augmentin ES-600)Drug: azithromycin SR
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 902
- Registration Number
- NCT00643292
- Locations
Pfizer Investigational Site
A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2011-05-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 693
- Registration Number
- NCT00643149
- Locations
- ๐ฎ๐ณ
Pfizer Investigational Site, Mumbai, Maharashtra, India
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2011-05-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 541
- Registration Number
- NCT00643409
- Locations
Pfizer Investigational Site
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2011-05-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 551
- Registration Number
- NCT00644449
- Locations
- ๐ป๐ช
Pfizer Investigational Site, Caracas, Venezuela
A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures
Phase 3
Completed
- Conditions
- Sleep DeprivationEpilepsies, Partial
- Interventions
- Drug: PlaceboDrug: Pregabalin
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2008-04-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 17
- Registration Number
- NCT00643136
- Locations
- ๐ณ๐ฑ
Pfizer Investigational Site, Heeze, Netherlands
Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2008-03-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 360
- Registration Number
- NCT00643539
- Locations
- ๐ซ๐ท
Pfizer Investigational Site, Versailles, France
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients
Phase 3
Completed
- Conditions
- Pneumonia
- Interventions
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2008-03-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 504
- Registration Number
- NCT00643227
- Locations
Pfizer Investigational Site
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients
Phase 3
Completed
- Conditions
- Pneumonia
- Interventions
- First Posted Date
- 2008-03-26
- Last Posted Date
- 2008-03-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 468
- Registration Number
- NCT00643734
- Locations
- ๐ท๐บ
Pfizer Investigational Site, Smolensk, Russian Federation
Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis
Phase 1
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: SBI-087
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT00641225
- Locations
- ๐จ๐ฆ
Pfizer Investigational Site, Montreal, Quebec, Canada
Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia
- First Posted Date
- 2008-03-20
- Last Posted Date
- 2009-03-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 270
- Registration Number
- NCT00639483
- Locations
- ๐จ๐ณ
Pfizer Investigational Site, Taipei, Taiwan
ยฉ Copyright 2025. All Rights Reserved by MedPath